BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 1,000 Shares

CEO of BioMarin Pharmaceutical Inc. (BMRN, Financial) Jean Jacques Bienaime sells 1,000 shares of BMRN on 09/08/2010 at an average price of $22.22 a share.

Biomarin Pharmaceutical Inc. has a market cap of $2.31 billion; its shares were traded at around $22.62 with a P/E ratio of 205.7 and P/S ratio of 7.1.

BMRN is in the portfolios of Richard Aster Jr of Meridian Fund, Columbia Wanger of Columbia Wanger Asset Management, PRIMECAP Management, RS Investment Management, Bruce Kovner of Caxton Associates, Pioneer Investments, George Soros of Soros Fund Management LLC, Chuck Royce of Royce& Associates.

CEO Recent Trades:

  • Sell: CEO Jean Jacques Bienaime sold 4,000 shares of BMRN stock on 09/02/2010 at the average price of 20.97. Jean Jacques Bienaime owns at least 95,067 shares after this. The price of the stock has increased by 7.87% since.

  • Sell: CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 08/30/2010 at the average price of 20.71. Jean Jacques Bienaime owns at least 99,067 shares after this. The price of the stock has increased by 9.22% since.

  • Sell: CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 08/30/2010 at the average price of 20.71. Jean Jacques Bienaime owns at least 99,067 shares after this. The price of the stock has increased by 9.22% since.

  • Sell: CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 08/27/2010 at the average price of 20.68. Jean Jacques Bienaime owns at least 99,067 shares after this. The price of the stock has increased by 9.38% since.



Directors and Officers Recent Trades:

  • Sell: VP, Human Resources Mark Wood sold 937 shares of BMRN stock on 09/07/2010 at the average price of 21.51. Mark Wood owns at least 14,243 shares after this. The price of the stock has increased by 5.16% since.

  • Sell: EVP, Chief Medical Officer Henry J Fuchs sold 834 shares of BMRN stock on 09/01/2010 at the average price of 20.88. Henry J Fuchs owns at least 31,000 shares after this. The price of the stock has increased by 8.33% since.

  • Sell: SVP, General Counsel George Eric Davis sold 15,657 shares of BMRN stock on 08/20/2010 at the average price of 20.57. George Eric Davis owns at least 27,901 shares after this. The price of the stock has increased by 9.97% since.

  • Sell: VP, Human Resources Mark Wood sold 2,500 shares of BMRN stock on 07/26/2010 at the average price of 21. Mark Wood owns at least 14,243 shares after this. The price of the stock has increased by 7.71% since.

  • Sell: EVP, Chief Medical Officer Henry J Fuchs sold 833 shares of BMRN stock on 07/23/2010 at the average price of 20. Henry J Fuchs owns at least 31,000 shares after this. The price of the stock has increased by 13.1% since.